Onego Bio is a game-changer food-biotech company producing animal-free egg protein with precision fermentation. The US-Finnish company is revolutionizing the food system by harnessing the power of precision fermentation to manufacture real egg protein entirely animal-free. Their ingredient, Bioalbumen®, sets a new standard for sustainable protein with identical taste and nutrition, superior functional properties and over 90% smaller environmental footprint compared to eggs from chickens. Onego’s highly efficient and scalable technology caters to the needs of the food industry searching for stable, sustainable functional ingredients. As a game-changer in the field, the company was selected the Winner of Fast Company’s 2023 World Changing Ideas awards and is a co-founder of two industry associations: Precision Fermentation Alliance and Food Fermentation Europe. Founded in 2022 and based in Finland, Onego Bio operates in the Biotechnology, Food and Beverage, and Manufacturing industries. Its latest milestone includes a €14.00M Venture Round investment at 18 July 2024 from the European Innovation Council. This investment signifies a strong strategic partnership that could propel Onego Bio into a position of market leadership within the plant-based protein industry.